Last reviewed · How we verify
NCT06365268: CONTRAST
Perinatal Thoraco-abdomino-pelvic Tumors Study
trial testing Collection of data from the patient's medical file in Perinatal Solid Tumors of the Thoraco-abdomino-pelvic Region in 152 participants. Completed in 10 October 2024.
10 October 2024
Quick facts
| Lead sponsor | Assistance Publique - Hôpitaux de Paris |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 152 |
| Start date | 5 September 2024 |
| Primary completion | 10 October 2024 |
| Estimated completion | 10 October 2024 |
| Sites | 5 locations across France |
Drugs / interventions tested
- Collection of data from the patient's medical file
Conditions studied
- Perinatal Solid Tumors of the Thoraco-abdomino-pelvic Region — all drugs for Perinatal Solid Tumors of the Thoraco-abdomino-pelvic Region →
Sponsor
Assistance Publique - Hôpitaux de Paris — full company profile →
Who can join
Under 3 Months, any sex, with Perinatal Solid Tumors of the Thoraco-abdomino-pelvic Region. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Congenital tumors are a rare diagnosis in the fetus and newborn. They differ from those of children and adults in terms of the nature, location and evolution of the tumor. Indeed, some histologically benign tumors may have lethal potential in utero (e.g. sacrococcygeal teratomas) or even undergo malignant transformation if left untreated. In contrast, other tumors that are malignant by histological criteria may have a very good prognosis, regressing spontaneously within the first year of life (e.g. neuroblastoma). Despite advances in imaging, benign and malignant solid tumors remain a major diagnostic and prognostic challenge in the antenatal context. The management of congenital tumors requires multidisciplinary expertise, taking into account the perinatal context, which poses specific problems, particularly in terms of therapeutic aspects, but also the frequent existence of associated malformations and/or genetic predisposition syndromes. This study focuses on solid tumors of the thoraco-abdomino-pelvic region, the main objective being to investigate the correlation between antenatal clinical and radiological analysis and confirmed postnatal diagnosis of congenital solid truncal tumors, as well as the developmental spectrum in which they fit.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Prenatal diagnosis and postnatal management of perinatal thoracoabdominopelvic tumors: multicenter experience.
Khawand C, Orbach D, Berrebi D, Branchereau S, et al · · 2025 · PMID 40847681 · DOI 10.1002/uog.70000
Verify or expand the search:
- PubMed search for NCT06365268
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Collection of data from the patient's medical file
Trials testing the same drug.
- NCT06683937 — Evaluation of Direct Antiviral Treatments Against SARS-CoV-2 in Immunocompromised Patients With Covid-19. A G2i Study, N · not yet recruiting
- NCT06650111 — Epidemiology, Diagnosis, Medical Care and Prognosis of Tubulointerstitial Nephritis: Results of a Multicenter Retrospect · completed
- NCT06517277 — Haemophilus Influenzae Pneumonia in Adults · completed
- NCT06297122 — Severe Group A Streptococcus Infections in Paris, France, 2018-2023 · completed
- NCT06046339 — Left Ventricular Ejection Fraction in Cardiac Arrest Survivors Treated With Extracorporeal Cardiopulmonary Resuscitation · completed
Other Assistance Publique - Hôpitaux de Paris trials
Trials by the same sponsor.
- NCT07443436 — Immunomodulatory Treatment of Interstitial Lung Disease Associated With Surfactant Related Gene Variants · Phase 2 · not yet recruiting
- NCT07499492 — Red Blood Cell Transfusion to Optimize Extubation · NA · not yet recruiting
- NCT07379918 — Real-life Evaluation of Endopredict® in Early HR+/HER2- Breast Cancer · recruiting
- NCT07473869 — Smartphone Application for Automated Measurement of Capillary Refill Time (CRT) · not yet recruiting
- NCT07505394 — Efficacy of a Prediction Model-based Algorithm to PREVENT Drug-induced Impulse Control Disorders in Parkinson's Disease · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06365268 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Assistance Publique - Hôpitaux de Paris
- Last refreshed: 19 September 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06365268.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing